| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/11/2011 | CN102048794A Isatis root oral liquid and preparation method thereof |
| 05/11/2011 | CN102048785A Application of eupatorium adenophorum spreng in preparation of veterinary medicine or feed additive |
| 05/11/2011 | CN102048769A Process for extracting polysaccharide from umbellate pore fungus |
| 05/11/2011 | CN102048742A Nano-scale liquid composite vitamin preparation |
| 05/11/2011 | CN102048741A Antiallergic medicament and application thereof |
| 05/11/2011 | CN102048728A Application of artemisinin derivative in preparation of medicaments for treating Crohn disease |
| 05/11/2011 | CN102048720A Tanshinol and notoginsenoside R1, as well as application of compatibility thereof for preventing and treating diseases caused by microcirculation disturbance |
| 05/11/2011 | CN102048714A Application of diphenol compounds in preparation of anti-complement medicaments |
| 05/11/2011 | CN102048712A Stable film agent medicinal composition containing allergen and preparation method thereof |
| 05/11/2011 | CN102048686A Application of yeast dextran injection for improving immune efficiency of foot-and-mouth disease vaccine of dairy cow |
| 05/11/2011 | CN102048683A Lentinan injection and preparation method thereof |
| 05/11/2011 | CN102048682A Loratadine cream and application thereof |
| 05/11/2011 | CN101716326B Medicament for treating children chronic cough and allergic rhinitis and preparation method thereof |
| 05/11/2011 | CN101648959B Coumaronochromones compound and preparation and application thereof |
| 05/11/2011 | CN101597612B SEC2 mutant gene with increased activity of super-antigen and preparation method thereof |
| 05/11/2011 | CN101584773B Chinese herbal medicament for treating skin diseases |
| 05/11/2011 | CN101485694B Method for extracting Ganoderma lucidum triterpenes components |
| 05/11/2011 | CN101455686B Health liquor |
| 05/11/2011 | CN101428033B Mix-configuration ginsenoside Rh2 and uses thereof |
| 05/11/2011 | CN101375737B Agent capable of inhibiting harmful substance in cigarette |
| 05/11/2011 | CN101361917B Traditional Chinese medicine preparation for enhancing immunity and promoting sleep |
| 05/11/2011 | CN101361916B Traditional Chinese medicine preparation for enhancing immunity and promoting sleep |
| 05/11/2011 | CN101340922B Caltrop freeze-dry extract used for antiallergic treatment |
| 05/11/2011 | CN101300341B Lactic acid bacterium having immunoregulatory activity derived from moromi for wine fermentation |
| 05/11/2011 | CN101254302B Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 05/11/2011 | CN101212983B A vaccine composition comprising alpha-galactosylceramide as an adjuvant for intranasal administration |
| 05/11/2011 | CN101195799B SOD distillate spirits and manufacturing method thereof |
| 05/11/2011 | CN101081315B Method for forming medical devices containing rapamycin analogs |
| 05/11/2011 | CN101032541B Echinacea purpurea extract and the preparing method and the content measuring method |
| 05/11/2011 | CN101027302B Pyrrolo-pyridine kinase modulators |
| 05/10/2011 | USRE42353 Quinazoline derivatives and pharmaceutical compositions containing them |
| 05/10/2011 | US7939646 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/10/2011 | US7939639 Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology |
| 05/10/2011 | US7939106 Surface stabilized fenofibrate particles have a particle size of 10 mu m or less; phospholipid surface modifier; dispersed in a bulking/ releasing matrix |
| 05/10/2011 | US7939105 Rapidly dispersing solid dry therapeutic dosage |
| 05/10/2011 | US7939086 Modified Vaccinia Ankara virus variant |
| 05/10/2011 | US7939062 Methods for human allografting |
| 05/10/2011 | US7938641 Extrusion die |
| 05/10/2011 | CA2519063C Immunomodulating heterocyclic compounds |
| 05/10/2011 | CA2483105C Autoimmune conditions and nadph oxidase defects |
| 05/10/2011 | CA2478335C Amino-methyl substituted tetracycline compounds |
| 05/10/2011 | CA2475498C Piperidine derivative and pharmaceutical composition comprising the same as active ingredient |
| 05/10/2011 | CA2463102C Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 05/10/2011 | CA2460436C Stabilization of active agents by formulation into nanoparticulate form |
| 05/10/2011 | CA2436935C Serine protease inhibitors |
| 05/10/2011 | CA2433158C Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
| 05/10/2011 | CA2419633C Substituted imidazoles as tafia inhibitors |
| 05/10/2011 | CA2417806C New immunoeffector compounds |
| 05/10/2011 | CA2344590C Treatment of inflammatory disease |
| 05/05/2011 | WO2011053653A2 Prevotella histicola preparations and the treatment of autoimmune conditions |
| 05/05/2011 | WO2011053468A1 Amino-benzoic acid derivatives for use in the treatment of dihydrogenase-related disorders |
| 05/05/2011 | WO2011052996A2 Novel lactobacillus plantarum and composition comprising the same |
| 05/05/2011 | WO2011052919A2 Novel alpha-galactosylceramide derivatives, pharmaceutically acceptable salts thereof, method for preparing same, and pharmaceutical composition for an immune adjuvant, containing the derivatives as active ingredients |
| 05/05/2011 | WO2011052830A1 Raspberry extract for enhancing skin immunity, combined pressure extraction method and extract therefrom |
| 05/05/2011 | WO2011052799A1 Compositions and methods for treating inflammatory disorders |
| 05/05/2011 | WO2011052706A1 Dry powder inhaler of tranilast having high solubility |
| 05/05/2011 | WO2011052697A1 Protein having cedar pollen immunogenicity, polynucleotide for coding for said protein, and uses of said protein and polynucleotide |
| 05/05/2011 | WO2011052638A1 Process for production of cytokine-induced killer cells |
| 05/05/2011 | WO2011051960A2 Process for the preparation of rapamycin derivatives |
| 05/05/2011 | WO2011051520A1 Triterpenic saponins from the crocus sativus corm as an adjuvant in protein vaccine formulations |
| 05/05/2011 | WO2011051452A1 N-containing heteroaryl derivatives as jak3 kinase inhibitors |
| 05/05/2011 | WO2011050590A1 Polymorph of 3-(substituteddihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and pharmaceutical compositions thereof |
| 05/05/2011 | WO2011039511A9 Agents, uses and methods |
| 05/05/2011 | WO2011027222A3 Immunogenic compositions including tlr activity modulators |
| 05/05/2011 | WO2010012069A8 Multivalent vaccines based on papaya mosaic virus and uses thereof |
| 05/05/2011 | US20110107443 Novel protein transduction domains derived from secretory leukocyte protease inhibitor |
| 05/05/2011 | US20110105620 Organic compounds |
| 05/05/2011 | US20110105607 Lipophilic diesters of chelating agent for inhibition of enzyme activity |
| 05/05/2011 | US20110105606 Compositions and methods affecting the signaling pathways of LRP receptors |
| 05/05/2011 | US20110105573 Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 05/05/2011 | US20110105548 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof |
| 05/05/2011 | US20110105535 Inhibitors of phosphatidylinositol 3-kinase |
| 05/05/2011 | US20110105509 Indole based receptor crth2 antagonists |
| 05/05/2011 | US20110105505 Thiazolyl piperidine derivatives |
| 05/05/2011 | US20110105499 Pyrazolo-Pyrazinone Compounds and Methods of Use Thereof |
| 05/05/2011 | US20110105498 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
| 05/05/2011 | US20110105495 CYCLOPENTATHIOPHENE MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 05/05/2011 | US20110105483 Triazole compounds that modulate hsp90 activity |
| 05/05/2011 | US20110105479 Inhibitors of Bruton's Tyrosine Kinase |
| 05/05/2011 | US20110105463 6-substituted phenoxychroman carboxylic acid derivatives |
| 05/05/2011 | US20110105458 Fatty acid inhibitors |
| 05/05/2011 | US20110105452 Oxidant Scavengers for Treatment of Diabetes or Use in Transplantation or Induction of Immune Tolerance |
| 05/05/2011 | US20110105450 Ophthalmic formulations of fluticasone and methods of use |
| 05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
| 05/05/2011 | US20110105434 2-amino purine derivatives and their use as anti-herpetic agents |
| 05/05/2011 | US20110105427 Deazapurines and uses thereof |
| 05/05/2011 | US20110105419 Pharmacological adjuvants based on coordination compounds of d-metals |
| 05/05/2011 | US20110105401 Peptide composition and a method of promoting cartilage formation |
| 05/05/2011 | US20110105387 Method of treatment with rapamycin |
| 05/05/2011 | US20110104304 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders |
| 05/05/2011 | US20110104296 Endorphin Therapy Compositions and Methods |
| 05/05/2011 | US20110104287 Fenoldopam formulations and pro-drug derivatives |
| 05/05/2011 | US20110104263 Claudin-4 binding peptides, compositions and methods of use |
| 05/05/2011 | US20110104260 Vaccine against varicella zoster virus |
| 05/05/2011 | US20110104248 Liposomes and immunopotentiating compositions containing the same |
| 05/05/2011 | US20110104216 Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product |
| 05/05/2011 | US20110104211 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/05/2011 | US20110104210 Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors |
| 05/05/2011 | US20110104209 Dna sequence, and recombinant preparation of the grass pollen allergen lol p4 |
| 05/05/2011 | US20110104208 Enzyme Treatment of Glucans |